The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
Article in Journal of Experimental & Clinical Cancer Research (June 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Journal of Experimental & Clinical Cancer Research (June 2024)
Article in Frontiers in Endocrinology (January 2024)
Preprint in bioRxiv (January 2024)